Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
Gespeichert in:
Veröffentlicht in: | Medical oncology (Northwood, London, England) London, England), 2013-12, Vol.30 (4), p.707-707, Article 707 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 707 |
---|---|
container_issue | 4 |
container_start_page | 707 |
container_title | Medical oncology (Northwood, London, England) |
container_volume | 30 |
creator | He, Lu Zhou, Xinke Qu, Chen Tang, Yunqiang Zhang, Qiong Hong, Jian |
description | |
doi_str_mv | 10.1007/s12032-013-0707-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1429845452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1429845452</sourcerecordid><originalsourceid>FETCH-LOGICAL-c259t-b0db1fda5c35b973d9fc7d21cc3e249c11f797f244045cc05be91b5261b5ff873</originalsourceid><addsrcrecordid>eNotkEtLAzEUhYMoWKs_wN0s6yKam0fTLKVoFYqCVXAhhEwmqZHpZEymYv-9KXVzX5x7OHwIXQK5BkLkTQZKGMUEGCaSSMyP0AiEUBgYvB-XmQmJiZiSU3SW8xchFARVI_Sxcmnd7mzoqsnqZfF0VcUfl9xvn1zOIXZVGZpgh1z1MaayxXUXc8hVefh0vRmidW27bU2qrEnFJm5MVc7BdUM-RyfetNld_Pcxeru_e50_4OXz4nF-u8SWCjXgmjQ1-MYIy0StJGuUt7KhYC1zlCsL4KWSnnJOuLCWiNopqAWdluL9TLIxmhx8S7zvrcuD3oS8z2U6F7dZA6dqxgUXtEjhILUp5pyc130KG5N2Gojek9QHkrqQ1HuSmrM_ulVoTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1429845452</pqid></control><display><type>article</type><title>Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients</title><source>SpringerNature Journals</source><creator>He, Lu ; Zhou, Xinke ; Qu, Chen ; Tang, Yunqiang ; Zhang, Qiong ; Hong, Jian</creator><creatorcontrib>He, Lu ; Zhou, Xinke ; Qu, Chen ; Tang, Yunqiang ; Zhang, Qiong ; Hong, Jian</creatorcontrib><identifier>ISSN: 1357-0560</identifier><identifier>EISSN: 1559-131X</identifier><identifier>DOI: 10.1007/s12032-013-0707-4</identifier><language>eng</language><ispartof>Medical oncology (Northwood, London, England), 2013-12, Vol.30 (4), p.707-707, Article 707</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c259t-b0db1fda5c35b973d9fc7d21cc3e249c11f797f244045cc05be91b5261b5ff873</citedby><cites>FETCH-LOGICAL-c259t-b0db1fda5c35b973d9fc7d21cc3e249c11f797f244045cc05be91b5261b5ff873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>He, Lu</creatorcontrib><creatorcontrib>Zhou, Xinke</creatorcontrib><creatorcontrib>Qu, Chen</creatorcontrib><creatorcontrib>Tang, Yunqiang</creatorcontrib><creatorcontrib>Zhang, Qiong</creatorcontrib><creatorcontrib>Hong, Jian</creatorcontrib><title>Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients</title><title>Medical oncology (Northwood, London, England)</title><issn>1357-0560</issn><issn>1559-131X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNotkEtLAzEUhYMoWKs_wN0s6yKam0fTLKVoFYqCVXAhhEwmqZHpZEymYv-9KXVzX5x7OHwIXQK5BkLkTQZKGMUEGCaSSMyP0AiEUBgYvB-XmQmJiZiSU3SW8xchFARVI_Sxcmnd7mzoqsnqZfF0VcUfl9xvn1zOIXZVGZpgh1z1MaayxXUXc8hVefh0vRmidW27bU2qrEnFJm5MVc7BdUM-RyfetNld_Pcxeru_e50_4OXz4nF-u8SWCjXgmjQ1-MYIy0StJGuUt7KhYC1zlCsL4KWSnnJOuLCWiNopqAWdluL9TLIxmhx8S7zvrcuD3oS8z2U6F7dZA6dqxgUXtEjhILUp5pyc130KG5N2Gojek9QHkrqQ1HuSmrM_ulVoTg</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>He, Lu</creator><creator>Zhou, Xinke</creator><creator>Qu, Chen</creator><creator>Tang, Yunqiang</creator><creator>Zhang, Qiong</creator><creator>Hong, Jian</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients</title><author>He, Lu ; Zhou, Xinke ; Qu, Chen ; Tang, Yunqiang ; Zhang, Qiong ; Hong, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c259t-b0db1fda5c35b973d9fc7d21cc3e249c11f797f244045cc05be91b5261b5ff873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Lu</creatorcontrib><creatorcontrib>Zhou, Xinke</creatorcontrib><creatorcontrib>Qu, Chen</creatorcontrib><creatorcontrib>Tang, Yunqiang</creatorcontrib><creatorcontrib>Zhang, Qiong</creatorcontrib><creatorcontrib>Hong, Jian</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical oncology (Northwood, London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Lu</au><au>Zhou, Xinke</au><au>Qu, Chen</au><au>Tang, Yunqiang</au><au>Zhang, Qiong</au><au>Hong, Jian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients</atitle><jtitle>Medical oncology (Northwood, London, England)</jtitle><date>2013-12-01</date><risdate>2013</risdate><volume>30</volume><issue>4</issue><spage>707</spage><epage>707</epage><pages>707-707</pages><artnum>707</artnum><issn>1357-0560</issn><eissn>1559-131X</eissn><doi>10.1007/s12032-013-0707-4</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1357-0560 |
ispartof | Medical oncology (Northwood, London, England), 2013-12, Vol.30 (4), p.707-707, Article 707 |
issn | 1357-0560 1559-131X |
language | eng |
recordid | cdi_proquest_miscellaneous_1429845452 |
source | SpringerNature Journals |
title | Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T16%3A56%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serglycin%20(SRGN)%20overexpression%20predicts%20poor%20prognosis%20in%20hepatocellular%20carcinoma%20patients&rft.jtitle=Medical%20oncology%20(Northwood,%20London,%20England)&rft.au=He,%20Lu&rft.date=2013-12-01&rft.volume=30&rft.issue=4&rft.spage=707&rft.epage=707&rft.pages=707-707&rft.artnum=707&rft.issn=1357-0560&rft.eissn=1559-131X&rft_id=info:doi/10.1007/s12032-013-0707-4&rft_dat=%3Cproquest_cross%3E1429845452%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1429845452&rft_id=info:pmid/&rfr_iscdi=true |